The case-only independence assumption: Associations between genetic polymorphisms and smoking among controls in two population-based studies

International Journal of Molecular Epidemiology and Genetics

Volumn 3, Issue 4, 2012, Pages 333-360

  Hodgson, M Elizabeth ^a   Olshan, Andrew F ^a,b   North, Kari E ^a,c   Poole, Charles L ^a   Zeng, Donglin ^a   Tse, Chiu Kit ^a   Keku, Tope O ^b   Galanko, Joseph ^a   Sandler, Robert ^b   Millikan, Robert C ^a,b,c  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Case only; Controls; Gene environment interaction; Genetic polymorphisms; Smoking

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; MALE; NORMAL HUMAN; POPULATION RESEARCH; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STUDY DESIGN; SYSTEMATIC ERROR;

EID: 84869848872     PISSN: None     EISSN: 19481756     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Prentice RL, Vollmer WM and Kalbfleisch JD. On the use of case series to identify disease risk factors. Biometrics 1984; 40: 445-458.
2. Piegorsch WW, Weinberg CR and Taylor JA. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat Med 1994; 13: 153-162.
3. Khoury MJ and Flanders WD. Nontraditional epidemiologic approaches in the analysis of gene- environment interaction: Case-controlstudies with no controls! Am J Epidemiol 1996; 144: 207-213.
4. Albert PS, Ratnasinghe D Tangrea J, and Wacholder S. Limitations of the case-only design for identifying gene-environment interactions. Am J Epidemiol 2001; 154: 687-693.
5. Mukherjee B, Ahn J, Gruber SB, Rennert G, Moreno V and Chatterjee N. Tests for gene-environment interaction from case-control data: A novel study of type I error, power and designs. Genet Epidemiol 2008; 32: 615-626.
6. Mukherjee B and Chatterjee N. Exploiting gene-environment independence for analysis of case-control studies: An empirical Bayestype shrinkage estimator to trade-off between bias and efficiency. Biometrics 2008; 64: 685-694.
7. Hodgson ME, Poole C, Olshan AF, North KE,Zeng D and Millikan RC. Smoking and selected DNA repair gene polymorphisms in controls: Systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2010; 19: 3055-3086.
8. Liu X, Fallin MD and Kao WHL. Genetic dissection methods: Designs used for tests of geneenvironment interaction. Curr Opin Genet Dev 2004; 14: 241-245.
9. Hall IJ, Moorman PG, Millikan RC and Newman B. Comparative analysis of breast cancer risk factors among African-American women and white women. Am J Epidemiol 2005; 161: 40-51.
10. II'yasova D, Martin C and Sandler RS. Tea intake and risk of colon cancer in African-Americans and Whites: North Carolina colon cancer study. Cancer Causes Control 2003; 14: 767-772.
11. Millikan R, Eaton A, Worley K, Biscocho L, Hodgson E, Huang WY, Geradts J, Iacocca M, Cowan D, Conway K and Dressler L. HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites. Breast Cancer Res Treat 2003; 79: 355-364.
12. Newman B, Moorman PG, Millikan R, Qaqish BF, Geradts J, Aldrich TE and Liu ET. The Carolina Breast Cancer Study: Integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat 1995; 35: 51-60.
13. Satia-Abouta J, Galanko JA, Potter JD, Ammerman A, Martin CF and Sandler RS. Associations of Total Energy and Macronutrients with Colon Cancer Risk in African Americans and Whites: Results from the North Carolina Colon Cancer Study. Am J Epidemiol 2003; 158: 951-962.
14. Weinberg CR and Sandler DP. Randomized recruitment in case-control studies. Am J Epidemiol 1991; 134: 421-432.
15. Duell EJ, Wiencke JK, Cheng TJ, Varkonyi A, ZuoZ F, Ashok TDS, Mark EJ, Wain JC, Christiani DC and Kelsey KT. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000; 21: 965-971.
16. Li Y, Millikan RC, Bell DA, Cui L, Tse CK, Newman B and Conway K. Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women. Breast Cancer Res 2004; 6: R460-R473.
17. Mechanic LE, Millikan RC, Player J, de Cotret AR, Winkel S, Worley K, Heard K, Heard K, Tse CK and Keku T. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: A population-based case-control study. Carcinogenesis 2006; 27: 1377-1385.
18. Millikan RC, Pittman GS, Newman B, Tse CKJ, Selmin O, Rockhill B, Savitz D, Moorman PG and Bell DA. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998; 7: 371-378.
19. Millikan R, Pittman G, Tse CK, Savitz DA, Newman B and Bell D. Glutathione S-transferases M1, T1, and P1 and breast cancer. Cancer Epidemiol Biomarkers Prev 2000; 9: 567-573.
20. Millikan RC. NAT1 *10 and NAT1 * 11 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2000; 9: 217-219.
21. Millikan RC, Player J, de Cotret AR, Moorman P, Pittman G, Vannappagari V, Tse CK and Keku T. Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case-control study of African Americans and whites. Breast Cancer Res 2004; 6: R264-R274.
22. Millikan RC, Player JS, DeCotret AR, Tse CK and Keku T. Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005; 14: 2326-2334.
23. Pachkowski BF, Winkel S, Kubota Y, Swenberg JA, Millikan RC and Nakamura J. XRCC1 genotype and breast cancer: Functional studies and epidemiologic data show interactions between XRCC1 codon 280 his and smoking. Cancer Res 2006; 66: 2860-2868.
24. Butler LM, Millikan RC, Sinha R, Keku T., Winkel S, Harlan B, Eaton A, Gammon MD and Sandler RS. Modification by N-acetyltransferase 1 genotype on the association between dietary heterocyclic amines and colon cancer in a multiethnic study. Mutat Res Fundam Mol Mech Mutagen 2008; 638: 162-174.
25. Butler LM, Sinha R, Millikan RC, Martin CF, Newman B, Gammon MD, Ammerman AS and Sandler RS. Heterocyclic amines, meat intake, and association with colon cancer in a population-based study. Am J Epidemiol 2003; 157: 434-445.
26. Hernan MA, Hernandez-Diaz S, Werler MM and Mitchell AA. Causal knowledge as a prerequisite for confounding evaluation: An application to birth defects epidemiology. Am J Epidemiol 2002; 155: 176-184.
27. SAS Institute Inc.Cary NC. SAS 9.1.3. 2002.
28. Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 1968; 70: 213-220.
29. Flegal KM. The effects of changes in smoking prevalence on obesity prevalence in the United States. Am J Public Health 2007; 97: 1510-1514.
30. Centers for Disease Control and Prevention NCfCDPaHP. Behavioral Risk Factor Surveillance System. Tobacco Use Data 2001 [cited 2009/10/03]. Centers for Disease Control and Prevention NCfCDPaHP 2009.
31. Landis J and Koch G. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
32. Smith GD, Lawlor DA, Harbord R, Timpson N, Day I and Ebrahim S. Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med 2007; 4: 1985-1992.
33. Chatterjee N and Wacholder S. Invited commentary: Efficient testing of gene-environment interaction. Am J Epidemiol 2009; 169: 231-233.
34. Smits KM, Benhamou S, Garte S, Weijenberg MP, Alamanos Y, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Boffetta P, Bouchardy C, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Coutelle C, Daly AK, Muzi G, Dolzan V, Duzhak TG, Farker K, Golka K, Haugen A, Hein DW, Hildesheim A, Hirvonen A, Hsieh LL, Ingelman-Sundberg M, Kalina I, Kang D, Katoh T, Kihara M, Ono-Kihara M, Kim H, Kiyohara C, Kremers P, Lazarus P, Le Marchand L, Lechner MC, London S, Manni JJ, Maugard CM, Morgan GJ, Morita S, Nazar-Stewart V, Kristensen VN, Oda Y, Parl FF, Peters WHM, Rannug A, Rebbeck T, Pinto LFR, Risch A, Romkes M, Salagovic J, Schoket B, Seidegard J, Shields PG, Sim E, Sinnett D, Strange RC, Stucker I, Sugimura H, To-Figueras J, Vineis P, Yu MC, Zheng W, Pedotti P and Taioli E. Association of metabolic gene polymorphisms with tobacco consumption in healthy controls. Int J Cancer 2004; 110: 266-270.
35. Hamajima N, Yuasa H, Matsuo K and Kurobe Y. Detection of gene-environment interaction by case-only studies. Jpn J Clin Oncol 1999; 29: 490-493.
36. Liu Y, Yoshimura K, Hanaoka T, Ohnami S, Ohnami S, Kohno T, Yoshida T, Sakamoto H, Sobue T and Tsugane S. Association of habitual smoking and drinking with single nucleotide polymorphism (SNP) in 40 candidate genes: Data from random population-based Japanese samples. J Hum Genet 2005; 50: 62-68.
37. Hildesheim A, Anderson LM, Chen CJ, Cheng YJ, Brinton LA, Daly AK, Reed CD, Chen IH, Caporaso NE, Hsu MM, Chen JY, Idle JR, Hoover RN, Yang CS and Chhabra SK. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in taiwan. J Natl Cancer Inst 1997; 89: 1207-1212.
38. Taylor JA, Umbach DM, Stephens E, Castranio T, Paulson D, Robertson C, Mohler JL and Bell DA. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: Evidence of a gene-gene-exposure three-way interaction. Cancer Res 1998; 58: 3603-3610.
39. Sugimura H, Wakai K, Genka K, Nagura K, Igarashi H, Nagayama K, Ohkawa A, Baba S, Morris BJ, Tsugane S, Ohno Y, Gao C, Li Z, Takezaki T, Tajima K and Iwamasa T. Association of Ile462Val (exon 7) polymorphism of cytochrome P450 IA1 with lung cancer in the Asian population: Further evidence from a case- control study in Okinawa. CancerEpidemiol Biomarkers Prev 1998; 7: 413-417.
40. Wu X, Shi H, Jiang H, Kemp B, Hong WK, Delclos GL and Spitz MR. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis 1997; 18: 967-973.
41. Egan KM, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Mignone LI, Farin F and Hunter DJ. Association of NAT2 and smoking in relation to breast cancer incidence in a population-based case-control study (United States). Cancer Causes Control 2003; 14: 43-51.
42. Marcus PM, Hayes RB, Vineis P, Garcia-Closas M, Caporaso NE, Autrup H, Branch RA, Brockmoller J, Ishizaki T, Karakaya AE, Ladero JM, Mommsen S, Okkels H, Romkes M, Roots I and Rothman N. Cigarette smoking, N-acetyltrans ferase 2 acetylation status, and bladder cancer risk: A case-series meta-analysis of a geneenvironment interaction. Cancer Epidemiol Biomarkers Prev 2000; 9: 461-467.
43. Rothman K. Modern Epidemiology, 3rd edition. 2008.
44. Gresner P, Gromadzinska J and Wasowicz W. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Lung Cancer 2007; 57: 1-25.
45. Nishikawa A, Mori Y, Lee IS, Tanaka T and Hirose M. Cigarette smoking, metabolic activation and carcinogenesis. Curr Drug Metab 2004; 5: 363-373.
46. Hecht SS, Carmella SG, Yoder A, Chen M, Li ZZ, Le C, Dayton R, Jensen J and Hatsukami DK. Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers. Cancer Epidemiol Biomarkers Prev 2006; 15: 1805-1811.
47. David SP and Munafo MR. Genetic variation in the dopamine pathway and smoking cessation. Pharmacogenomics 2008; 9: 1307-1321.
48. Breitling LP, Dahmen N, Illig T, Rujescu D, Nitz B, Raum E, Winterer G, Rothenbacher D and Brenner H. Variants in COMT and spontaneous smoking cessation: Retrospective cohort analysis of 925 cessation events. Pharmacogenet Genomics 2009; 19: 657-659.
49. Omidvar M, Stolk L, Uitterlinden AG, Hofman A, Van Duijn CM and Tiemeier H. The effect of catechol-O-methyltransferase Met/Val functional polymorphism on smoking cessation: retrospective and prospective analyses in a cohort study. Pharmacogenet Genomics 2009; 19: 45-51.
50. Chen X and Woodcroft KJ. Polymorphisms in metabolic genes CYP1A1 and GSTM1 and changes in maternal smoking during pregnancy. Nicotine Tob Res 2009; 11: 225-233.
51. Bierut LJ. Convergence of genetic findings for nicotine dependence and smoking related diseases with chromosome 15q24-25. Trends Pharmacol Sci 2010; 31: 46-51.